The investor cannot join for three weeks. Before postponing the strategy session, separate the investor's possible contributions: decision authority, specific information and facilitation. A guided session can supply process, and an asynchronous brief can supply information. Reserved approval still needs the person authorized to give it.
The harder question is whether waiting for more input can improve the choice enough to justify the delay. Build the session around that question and the smallest commitment the team can responsibly make now.
Define the commitment being delegated
“Choose our enterprise strategy” bundles market selection, product work, spending and customer promises. Unbundle it into a decision the team can make inside existing authority: for example, which segment receives a bounded discovery effort while product commitments remain unchanged.
State the authorization in operational terms: spending cap, people available, promises permitted and expiry date. Identify what would trigger an approval request. Investor sponsorship of the workshop does not establish authority over every resulting commitment.
Send the absent investor a short pre-read asking for missing facts and relevant constraints. Request the basis of comparable-company anecdotes: buyer, offer, acquisition route and period. Give that input a clear place in the evidence pack without turning it into an instruction to favor one option.
Identify the uncertainty that can reverse the choice
Suppose a fictional company must choose between a hospital offer and its existing clinic offer. Over the same planning horizon, the team estimates these net contributions, in thousands of euros, including the proposed delivery costs:
| Action | Hospital delivery proves manageable | Hospital delivery proves expensive |
|---|---|---|
| Pursue hospitals | 80 | -40 |
| Continue with clinics | 20 | 20 |
Assume, for illustration, a 40% chance of manageable delivery. Hospitals have expected contribution of 8: 0.4 × 80 plus 0.6 × -40. Clinics have 20. Under these assumptions and an expected-value criterion, clinics are preferable.
The hospital choice becomes preferable when the probability of manageable delivery exceeds 50%. That switching point is the session's useful question: what evidence could move the estimate across it? Debating whether the probability is 35% or 40% would not change this choice.
Check the payoff assumptions too. A different delivery cost, a strategic constraint or an unacceptable downside can change the decision even with unchanged probabilities. The table is an illustrative supporting model, not a product-generated forecast.
Put an upper bound on the value of waiting
Berkeley's decision-analysis treatment of information value compares the best expected choice now with the expected value of choosing after observing information. Information matters through the decisions it can change.
With perfect knowledge of hospital delivery in this simplified example, choose hospitals in the manageable case and clinics otherwise. Expected contribution becomes 44: 0.4 × 80 plus 0.6 × 20. Compared with choosing clinics now at 20, perfect resolution is worth 24, or €24,000.
That is an upper bound within this model for information resolving this uncertainty. A real scoping exercise is imperfect; it cannot automatically justify spending €24,000. Include its cost, delay, likelihood of changing the choice and any options lost while waiting. Ask which result would cause each action before commissioning the work.
If investor input cannot change the choice or its authorization, schedule the session now. If a single introduction could resolve the purchasing path, request that contribution directly. Waiting for a broad advisory conversation may be a costly way to acquire one missing fact.
Keep the status quo explicit in the comparison. A failed clinic test would weaken the clinic payoff estimate; it would not automatically validate hospital demand or delivery. Recompute the available choices using the changed evidence, including pausing investment. Otherwise a two-option workshop can create a false obligation to pursue the runner-up whenever the first choice disappoints. The purpose of preserving alternatives is to retain judgment, including the option to stop.
Protect the session from ceremonial dissent
Before discussing preferences, collect each participant's decisive observation and strongest objection. Invite the delivery lead whose evidence challenges the founder's model to explain it directly.
Nemeth, Brown and Rogers' experiment found advantages for authentic minority dissent over several assigned devil's-advocate conditions on the tasks studied. That supports taking actual objections seriously; appointing someone to argue against the plan does not substitute for hearing the colleague who believes it is wrong.
Ask the dissenter what their objection predicts. “Hospitals are difficult” becomes: procurement requires an approval sequence that prevents a paid pilot within the proposed window. Record what evidence would resolve that claim. Do not require the person to soften it into a consensus phrase before it enters the canvas.
If the founder retains the choice, say so. Consultation can expose errors without implying unanimous agreement or a vote that the founder can later disregard.
Run a session that preserves the unresolved branch
For a one-hour Beachhead working block, reserve the opening ten minutes for authority and the switching assumption. Use the main discussion to compare reachable buyers, purchasing paths and serviceability. Reserve the final ten minutes for the commitment, contrary evidence and investor handoff. This is a suggested allocation within the broader session, with additional preparation handled beforehand.
Teams Facilitator guides the framework discussion and captures shared work. Bring the payoff comparison as context; verify every number and preserve uncertainty when reviewing the record. A Bullseye session suits acquisition experiments, while Business Model Canvas suits linked delivery and revenue assumptions.
Keep branches explicit. A clinic test can proceed while hospital scoping remains open, provided both fit the same capacity envelope. Otherwise “keeping options open” can quietly commit the team to two strategies at once.
Send an investor handoff with a response that can matter
Send the reviewed summary with five fields: authorized action, decisive assumption, strongest objection, resource limit and requested contribution. Give the contribution a deadline linked to the decision.
For example: “We will continue clinic outreach within existing capacity. Before committing hospital engineering, we need a representative integration scoped. Please introduce an implementation operator by Friday; their evidence could change the estimate around our 50% switching point. No customer delivery date is authorized.”
Specify what reopens the choice: new scoping evidence, a changed payoff or an exceeded limit. General investor enthusiasm can be recorded without restarting the analysis. Use the next session to examine what actually changed.
Start a guided session, use the portfolio rollout guide to agree delegation across companies, and use the review checklist to evaluate the resulting experiment. Request another framework if the decision needs a different facilitated format.